CoChat

P2X7 receptor: A potential therapeutic target for autoimmune diseases

Cao, Fan, Hu, Li-Qin, Yao, Shu-Ran, Hu, Yan, Wang, De-Guang, Fan, Yin-Guang, Pan, Gui-Xia, Tao, Sha-Sha, Zhang, Qin, Pan, Hai-Feng, Wu, Guo-Cui · 2019 · Autoimmunity Reviews
Cited by 98

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

P2X7 receptor (P2X7R), a distinct ligand-gated ion channel, is a member of purinergic type 2 receptor family with ubiquitous expression in human body. Previous studies have revealed a pivotal role of P2X7R in innate and adaptive immunity. Once activated, it will meditate some vital cascaded responses including the assembly of nucleotide-binding domain (NOD) like receptor protein 3 (NLRP3) inflammasome, non-classical secretion of IL-1β, modulation of cytokine-independent pathways in inflammation such as P2X7R- transglutaminase-2 (TG2) and P2X7R-cathepsin pathway, activation and regulation of T cells, etc. In fact, above responses have been identified to be involved in the development of autoimmunity, specifically, the NLRP3 inflammasome could promote inflammation in massive autoimmune diseases and TG2, as well as cathepsin may contribute to joint destruction and degeneration in inflammatory arthritis. Recently, numerous evidences further suggested the significance of P2X7R in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS), etc. In this review, we will succinctly discuss the biological characteristics and summarize the recent progress of the involvement of P2X7R in the development and pathogenesis of autoimmune diseases, as well as its clinical implications and therapeutic potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.autrev.2019.06.009

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 98

Metadata

Authors
Cao, F., Hu, L.-Q., Yao, S.-R., Hu, Y., Wang, D.-G., Fan, Y.-G., Pan, G.-X., Tao, S.-S., Zhang, Q., Pan, H.-F., & Wu, G.-C.
Venue
Autoimmunity Reviews
Publisher
Elsevier BV
Published
2019-08
Volume
18
Issue
8
Pages
767-777
ISSN
1568-9972 (ISSN-L)
OpenAlex
W2950884881
Cited by
98
References
17
FWCI
7.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: P2X7 receptor: A potential therapeutic target for autoimmune diseases. https://app.cochat.ai/papers/10.1016/j.autrev.2019.06.009
The paper
Cao, F., Hu, L.-Q., Yao, S.-R., Hu, Y., Wang, D.-G., Fan, Y.-G., Pan, G.-X., Tao, S.-S., Zhang, Q., Pan, H.-F., & Wu, G.-C. (2019). P2X7 receptor: A potential therapeutic target for autoimmune diseases. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2019.06.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.